<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Surg Endosc</journal-id><journal-id journal-id-type="iso-abbrev">Surg Endosc</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Surgical Endoscopy</journal-title></journal-title-group><issn pub-type="ppub">0930-2794</issn><issn pub-type="epub">1432-2218</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11362387</article-id><article-id pub-id-type="pmcid-ver">PMC11362387.1</article-id><article-id pub-id-type="pmcaid">11362387</article-id><article-id pub-id-type="pmcaiid">11362387</article-id><article-id pub-id-type="pmid">39039294</article-id><article-id pub-id-type="doi">10.1007/s00464-024-11040-1</article-id><article-id pub-id-type="publisher-id">11040</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>New persistent opioid use following robotic-assisted, laparoscopic and open surgery inguinal hernia repair</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>MacQueen</surname><given-names initials="IT">Ian T.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Milky</surname><given-names initials="G">Gediwon</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shih</surname><given-names initials="IF">I.-Fan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zheng</surname><given-names initials="F">Feibi</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0517-9973</contrib-id><name name-style="western"><surname>Chen</surname><given-names initials="DC">David C.</given-names></name><address><email>dcchen@mednet.ucla.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution>Department of Surgery, </institution><institution>David Geffen School of Medicine at UCLA, </institution></institution-wrap>Los Angeles, CA USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05g2n4m79</institution-id><institution-id institution-id-type="GRID">grid.420371.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0417 4585</institution-id><institution>Global Access, Value &amp; Economics, Intuitive Surgical, </institution></institution-wrap>Sunnyvale, CA USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02pttbw34</institution-id><institution-id institution-id-type="GRID">grid.39382.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2160 926X</institution-id><institution>DeBakey Department of Surgery, </institution><institution>Baylor College of Medicine, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution>UCLA Division of General Surgery, </institution></institution-wrap>Los Angeles, USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution>Lichtenstein Amid Hernia Clinic at UCLA, </institution></institution-wrap>Los Angeles, USA </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><volume>38</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">469668</issue-id><fpage>5153</fpage><lpage>5159</lpage><history><date date-type="received"><day>24</day><month>4</month><year>2024</year></date><date date-type="accepted"><day>30</day><month>6</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>31</day><month>08</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-31 01:25:26.800"><day>31</day><month>08</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="464_2024_Article_11040.pdf"/><abstract id="Abs1"><sec><title>Introduction</title><p id="Par1">Post-operative prescription opioid use is a known risk factor for persistent opioid use. Despite the increased utilization of robotic-assisted surgery (RAS) for inguinal hernia repair (IHR), little is known whether this minimally invasive approach results in less opioid consumption. In this study, we compare long-term opioid use between RAS versus laparoscopic (Lap) versus open surgery for IHR.</p></sec><sec><title>Methods</title><p id="Par2">A retrospective cohort study of opioid-na&#239;ve patients who underwent outpatient primary IHR was conducted using the Merative&#8482; MarketScan&#174; (Previously IBM MarketScan&#174;) Databases between 2016 and 2020. Patients not continuously enrolled 180&#160;days before/after surgery, who had malignancy, pre-existing chronic pain, opioid dependency, or invalid prescription fill information were excluded. Among patients exposed to opioids peri-operatively, we assessed long-term opioid use as any opioid prescription fill within 90 to 180&#160;days post-surgery. Secondary outcomes were controlled substance schedule II/III opioid fill, and high-dose opioid fill defined as&#8201;&gt;&#8201;50 morphine milligram equivalent per day. An Inverse-probability of treatment weighted logistic regression was used to compare outcomes between groups with <italic toggle="yes">p</italic>-value of&#8201;&lt;&#8201;0.05 considered statistically significant.</p></sec><sec><title>Results</title><p id="Par3">A total of 41,271 patients were identified (2070 (5.0%) RAS, 16,704 (40.5%) Lap, and 22,497 (54.5%) open surgery). RAS was associated with less likelihood of prescription fills for any opioid (OR 0.78, 95% CI 0.60 to 0.98 versus Lap; OR 0.67, 95% CI 0.52 to 0.85 versus open), and schedule II/III opioid (OR 0.74, 95% CI 0.56 to 0.96 versus Lap; OR 0.68, 95% CI 0.51 to 0.88 versus open), but comparable high-dose opioid fill (OR 0.95, 95% CI 0.54 to 1.55 versus Lap; OR 0.96, 95% CI 0.56 to 1.52 versus open). Lap and open surgery had no significant difference.</p></sec><sec><title>Conclusion</title><p id="Par4">In this cohort of patients derived from a national commercial claims dataset, patients undergoing RAS had a decreased risk of long-term opioid use compared to laparoscopic and open surgery patients undergoing IHR.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00464-024-11040-1.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Persistent opioid use</kwd><kwd>Robotic surgery</kwd><kwd>Minimally invasive surgery</kwd><kwd>Inguinal hernia repair</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010477</institution-id><institution>Intuitive Surgical</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Science+Business Media, LLC, part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par5">The opioid epidemic is devastating in its scope and its impact on the lives of those affected. Three million Americans are afflicted by opioid use disorder and drug overdoses now account for over 90,000 deaths annually in the United States [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Mitigation strategies have included treatments for those affected and prevention efforts to avoid long-term opioid use and abuse. Exposure to opioid medication around the time of surgery is a clear risk factor for long-term opioid use [<xref ref-type="bibr" rid="CR3">3</xref>]. It is incumbent upon surgeons to understand the risks specific to individual patients and operations in order to combat the rising prevalence of chronic opioid use and addiction.</p><p id="Par6">Inguinal hernia repair is a very common procedure and is associated with more pain as compared to many outpatient operations. Over 800,000 inguinal hernia repairs has been estimated to happen every year in the United States [<xref ref-type="bibr" rid="CR4">4</xref>]. Prior studies suggest that greater than 90% of inguinal hernia repair patients are discharged with an opioid prescription following surgery [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. It is unknown how many of these patients become long-term users of opioids, and what patient and operative factors impact the risk of progressing to long-term opioid use.</p><p id="Par7">There are multiple methods and approaches for performing inguinal hernia repair including open techniques and minimally invasive techniques by laparoscopy (Lap) or robotic-assisted surgery (RAS). For mesh-based repair, the approach is not considered to significantly affect recurrence, and has little clear impact on the development of severe chronic-post operative pain [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Clinical circumstances often dictate which approach is ideal, such as selecting open mesh repair for patients with high cardiac risk who wish to avoid general anesthesia or minimally invasive repair for patients with recurrence after prior open repair [<xref ref-type="bibr" rid="CR8">8</xref>]. For the majority of patients, any of these options is reasonable and the recommendation is often based on perceived minor benefits of one technique over another or on surgeon preference. Minimally invasive preperitoneal mesh repair is commonly considered to cause less acute post-operative pain as compared to open mesh repair, though data on this are conflicting [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Overall, patterns of pain and analgesic use after these operations are incompletely understood.</p><p id="Par8">Prior studies have examined different approaches to repair and the association with opioid use in the short-term post-operative period [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Other studies have examined an association between prescribing patterns and amount of opioid use post operatively [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Although these outcomes are crucial in understanding the health impacts and financial costs of these operations in the short-term, any link between these short-term outcomes and progression to long-term opioid use is less understood. The present study aims to assess for an association between surgical approach in inguinal hernia repair and long-term opioid use. An a priori study protocol was prepared outlining the study design, variables and outcomes definition and the intended analysis. The intended analysis was to compare outcomes between surgical approaches (RAS, Lap, and Open) using logistic regression accounting for inverse probability of treatment weights (IPTW). The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for reporting cohort studies, but it was not registered in a study repository.</p><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Study design</title><p id="Par9">A retrospective cohort study was conducted using the Merative&#8482; MarketScan&#174; Research Databases, a large dataset which captures de-identified inpatient, outpatient and pharmacy service claims for over 273 million patients with employer-sponsored health insurance benefits [<xref ref-type="bibr" rid="CR12">12</xref>]. The database includes de-identified healthcare information compliant to the Health Insurance Portability and Accountability Act (HIPAA), and as such the study was considered exempt from review by the institutional review board in accordance with 45 CFR &#167;46.</p><p id="Par10">The study population was adults (&#8805;&#8201;18 years old) who underwent outpatient primary inguinal hernia repair between 2016 and 2020. As shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>, patients were required to be opioid-na&#239;ve (no opioid prescription between 30 and 180 days before surgery), and get exposed to opioid medication in the perioperative period (30 days before to 14 days after surgery). Consistent with prior studies, this was done to ensure only opioid-na&#239;ve patients who were exposed to opioids perioperatively are included [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Exposure to opioid during the peri-operative period was identified with at least one opioid prescription fill from pharmacy claim, or procedure claim for injectable opioid during surgery. Patients were excluded if they had bilateral repair, were not continuously enrolled in medical and pharmacy insurance benefit, had malignancy, metastatic cancer, chronic pain, or opioid abuse/dependency diagnosis in the 180 days before surgery, or had invalid prescription fill information (zero/negative quantity supplied or days of supply). The International Classification of Diseases, Tenth Revision (ICD-10) codes, and the Current Procedural Terminology (CPT) codes shown in eTable 1 were used identify patient population, and differentiate surgical approaches (RAS, Lap, and Open).<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Study design</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="464_2024_11040_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec4"><title>Outcome variables</title><p id="Par11">The primary outcome for this study was long-term opioid use, defined as one or more opioid prescription filled between 90 and 180 days after surgery. This definition was consistent with prior studies, and a surrogate for post-surgical chronic pain per the International Association for Study of Pain 2019 definition [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Further, we assessed prescription fill for controlled substance schedule II or III opioids, per the Drug Enforcement Administration (DEA) classification, and high-dose opioid prescription fill, defined as over 50 morphine milligram equivalent (MME) opioid dose per day in the long-term. These definitions were considered to represent high-risk opioid use because of the potential of abuse with Schedule II/III opioids, and increased overdose risk with over 50 MME per day dosing with minimal additional benefit to the patient [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p></sec><sec id="Sec5"><title>Study covariates</title><p id="Par12">Patient characteristics assessed include age, sex, area-level income, region of residence, metropolitan residence status, type of health insurance plan, Charlson comorbidity score [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], tobacco abuse and/or history, alcohol abuse and/or dependence, obesity/overweight status, mental health problem, and year of surgery. Types of health insurance plan were preferred provider organization (PPO), comprehensive insurance, health maintenance organization (HMO), point-of-service (POS) and other insurance plans.</p></sec><sec id="Sec6"><title>Statistical analysis</title><p id="Par13">Descriptive statistical analysis of baseline patient characteristics was conducted by surgical approach. Outcomes were compared between RAS versus Lap, RAS versus open, and Lap versus open groups separately. To adjust for difference between groups and minimize selection bias, stabilized inverse probability of treatment weighting (IPTW) was performed when comparing outcomes for each cohort. Multivariable logistic regression including all baseline patient characteristics as covariates was used to generate propensity score for the calculation of IPTW. Adjustment with IPTW creates a synthetic sample which is independent of covariates and allows for estimation of unbiased average treatment effects [<xref ref-type="bibr" rid="CR19">19</xref>]. To ensure no residual differences exist between groups, baseline characteristics were compared before and after IPTW adjustment using standardized mean/proportion difference, with&#8201;&lt;&#8201;0.1 difference considered comparable. All analyses were performed using R statistical software (version 4.2.2) [<xref ref-type="bibr" rid="CR20">20</xref>]. A <italic toggle="yes">p-</italic>value of&#8201;&lt;&#8201;0.05 was considered statistically significant.</p></sec></sec><sec id="Sec7"><title>Results</title><p id="Par14">A total of 116,259 patients aged&#8201;&#8805;&#8201;18 years old who had outpatient primary inguinal hernia repair were identified from the Merative&#8482; MarketScan&#174; databases between 2016 and 2020. After applying exclusion criteria, 41,271 patients remained in the study sample, of whom 2070 (5.0%) had RAS, 16,704 (40.5%) Lap, and 22,497 (54.5%) open surgery (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). As shown in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, most of the sample were male (37,667 [91.3%]), had zero Charlson&#8217;s comorbidity score (332,619 [79.0%]), and over one-half of them had preferred payor organization health insurance plan (20,969 [50.8%]). Among open surgery group, there were greater proportion of&#8201;&#8805;&#8201;65 years old patients (<italic toggle="yes">n</italic>&#8201;=&#8201;3427 [15.2%] versus RAS: <italic toggle="yes">n</italic>&#8201;=&#8201;94 [4.5%], Std Diff.&#8201;=&#8201;&#8722;&#8201;0.364; and Lap: <italic toggle="yes">n</italic>&#8201;=&#8201;1549 [9.3%], Std Diff.&#8201;=&#8201;0.183), and greater proportion of patients with&#8201;&#8805;&#8201;2 Charlson comorbidity score (<italic toggle="yes">n</italic>&#8201;=&#8201;1821 [8.1%] versus RAS: <italic toggle="yes">n</italic>&#8201;=&#8201;108 [5.2%], Std Diff.&#8201;=&#8201;0.108; and Lap: <italic toggle="yes">n</italic>&#8201;=&#8201;901 [5.4%], Std Diff.&#8201;=&#8201;&#8722;&#8201;0.116). In contrast, there were greater proportion of obese/overweight patients in RAS (<italic toggle="yes">n</italic>&#8201;=&#8201;261, [12.6%] versus Lap: <italic toggle="yes">n</italic>&#8201;=&#8201;1538 [9.2%], Std Diff.&#8201;=&#8201;0.109, and Open: <italic toggle="yes">n</italic>&#8201;=&#8201;1939 [8.6%], Std Diff.&#8201;=&#8201;0.130), and greater proportion of metropolitan residing patients (<italic toggle="yes">n</italic>&#8201;=&#8201;1276 [83.4%] versus Lap: <italic toggle="yes">n</italic>&#8201;=&#8201;13,069 [78.2%], Std Diff.&#8201;=&#8201;0.131, and open: <italic toggle="yes">n</italic>&#8201;=&#8201;16,799 [74.7%], Std Diff.&#8201;=&#8201;0.215). After IPTW, all baseline characteristics were comparable (Std Diff.&#8201;&lt;&#8201;0.1) between surgical approaches (eTable 2).<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Sample selection flowchart</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="464_2024_11040_Fig2_HTML.jpg"/></fig><table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Sample baseline characteristics before inverse-probability of treatment weighting</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Characteristic</th><th align="left" rowspan="2" colspan="1">Overall,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;41,271</th><th align="left" rowspan="2" colspan="1">Open,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;22,497</th><th align="left" rowspan="2" colspan="1">Lap,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;16,704</th><th align="left" rowspan="2" colspan="1">RAS,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;2070</th><th align="left" colspan="3" rowspan="1">Standardized difference</th></tr><tr><th align="left" colspan="1" rowspan="1">RAS vs lap</th><th align="left" colspan="1" rowspan="1">RAS vs open</th><th align="left" colspan="1" rowspan="1">Lap vs open</th></tr></thead><tbody><tr><td align="left" colspan="8" rowspan="1">Age, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;18&#8211;44&#160;years</td><td char="(" align="char" colspan="1" rowspan="1">11,117 (26.9)</td><td char="(" align="char" colspan="1" rowspan="1">5615 (25.0)</td><td char="(" align="char" colspan="1" rowspan="1">4867 (29.1)</td><td char="(" align="char" colspan="1" rowspan="1">635 (30.7)</td><td char="." align="char" colspan="1" rowspan="1">0.034</td><td char="." align="char" colspan="1" rowspan="1">0.128</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.094</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;45&#8211;54&#160;years</td><td char="(" align="char" colspan="1" rowspan="1">10,069 (24.4)</td><td char="(" align="char" colspan="1" rowspan="1">5154 (22.9)</td><td char="(" align="char" colspan="1" rowspan="1">4359 (26.1)</td><td char="(" align="char" colspan="1" rowspan="1">556 (26.9)</td><td char="." align="char" colspan="1" rowspan="1">0.017</td><td char="." align="char" colspan="1" rowspan="1">0.092</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.074</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;55&#8211;64&#160;years</td><td char="(" align="char" colspan="1" rowspan="1">15,015 (36.4)</td><td char="(" align="char" colspan="1" rowspan="1">8301 (36.9)</td><td char="(" align="char" colspan="1" rowspan="1">5929 (35.5)</td><td char="(" align="char" colspan="1" rowspan="1">785 (37.9)</td><td char="." align="char" colspan="1" rowspan="1">0.050</td><td char="." align="char" colspan="1" rowspan="1">0.021</td><td char="." align="char" colspan="1" rowspan="1">0.029</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;65+&#8201;</td><td char="(" align="char" colspan="1" rowspan="1">5070 (12.3)</td><td char="(" align="char" colspan="1" rowspan="1">3427 (15.2)</td><td char="(" align="char" colspan="1" rowspan="1">1549 (9.3)</td><td char="(" align="char" colspan="1" rowspan="1">94 (4.5)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.187</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.364</td><td char="." align="char" colspan="1" rowspan="1">0.183</td></tr><tr><td align="left" colspan="1" rowspan="1">Sex, male, <italic toggle="yes">n</italic> (%)</td><td char="(" align="char" colspan="1" rowspan="1">37,667 (91.3)</td><td char="(" align="char" colspan="1" rowspan="1">20,509 (91.2)</td><td char="(" align="char" colspan="1" rowspan="1">15,256 (91.3)</td><td char="(" align="char" colspan="1" rowspan="1">1902 (91.9)</td><td char="." align="char" colspan="1" rowspan="1">0.020</td><td char="." align="char" colspan="1" rowspan="1">0.026</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.006</td></tr><tr><td align="left" colspan="8" rowspan="1">Annual income, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&lt;&#8201;$35,000</td><td char="(" align="char" colspan="1" rowspan="1">3370 (8.2)</td><td char="(" align="char" colspan="1" rowspan="1">1995 (8.9)</td><td char="(" align="char" colspan="1" rowspan="1">1238 (7.4)</td><td char="(" align="char" colspan="1" rowspan="1">137 (6.6)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.031</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.084</td><td char="." align="char" colspan="1" rowspan="1">0.053</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;$35,000&#8211;$40,000</td><td char="(" align="char" colspan="1" rowspan="1">11,824 (28.6)</td><td char="(" align="char" colspan="1" rowspan="1">6537 (29.1)</td><td char="(" align="char" colspan="1" rowspan="1">4696 (28.1)</td><td char="(" align="char" colspan="1" rowspan="1">591 (28.6)</td><td char="." align="char" colspan="1" rowspan="1">0.010</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.011</td><td char="." align="char" colspan="1" rowspan="1">0.021</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;$40,000+</td><td char="(" align="char" colspan="1" rowspan="1">16,819 (40.8)</td><td char="(" align="char" colspan="1" rowspan="1">9153 (40.7)</td><td char="(" align="char" colspan="1" rowspan="1">6962 (41.7)</td><td char="(" align="char" colspan="1" rowspan="1">704 (34.0)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.159</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.138</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.020</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Unknown</td><td char="(" align="char" colspan="1" rowspan="1">9258 (22.4)</td><td char="(" align="char" colspan="1" rowspan="1">4812 (21.4)</td><td char="(" align="char" colspan="1" rowspan="1">3808 (22.8)</td><td char="(" align="char" colspan="1" rowspan="1">638 (30.8)</td><td char="." align="char" colspan="1" rowspan="1">0.182</td><td char="." align="char" colspan="1" rowspan="1">0.216</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.034</td></tr><tr><td align="left" colspan="8" rowspan="1">Region, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Northeast</td><td char="(" align="char" colspan="1" rowspan="1">7649 (18.5)</td><td char="(" align="char" colspan="1" rowspan="1">4597 (20.4)</td><td char="(" align="char" colspan="1" rowspan="1">2745 (16.4)</td><td char="(" align="char" colspan="1" rowspan="1">307 (14.8)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.044</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.147</td><td char="." align="char" colspan="1" rowspan="1">0.103</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;North Central</td><td char="(" align="char" colspan="1" rowspan="1">10,290 (24.9)</td><td char="(" align="char" colspan="1" rowspan="1">5546 (24.7)</td><td char="(" align="char" colspan="1" rowspan="1">4096 (24.5)</td><td char="(" align="char" colspan="1" rowspan="1">648 (31.3)</td><td char="." align="char" colspan="1" rowspan="1">0.152</td><td char="." align="char" colspan="1" rowspan="1">0.149</td><td char="." align="char" colspan="1" rowspan="1">0.003</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;South</td><td char="(" align="char" colspan="1" rowspan="1">16,809 (40.7)</td><td char="(" align="char" colspan="1" rowspan="1">8812 (39.2)</td><td char="(" align="char" colspan="1" rowspan="1">7149 (42.8)</td><td char="(" align="char" colspan="1" rowspan="1">848 (41.0)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.037</td><td char="." align="char" colspan="1" rowspan="1">0.037</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.074</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;West</td><td char="(" align="char" colspan="1" rowspan="1">6402 (15.5)</td><td char="(" align="char" colspan="1" rowspan="1">3470 (15.4)</td><td char="(" align="char" colspan="1" rowspan="1">2669 (16.0)</td><td char="(" align="char" colspan="1" rowspan="1">263 (12.7)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.094</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.078</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.015</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Unknown</td><td char="(" align="char" colspan="1" rowspan="1">121 (0.3)</td><td char="(" align="char" colspan="1" rowspan="1">72 (0.3)</td><td char="(" align="char" colspan="1" rowspan="1">45 (0.3)</td><td char="(" align="char" colspan="1" rowspan="1">4 (0.2)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.016</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.025</td><td char="." align="char" colspan="1" rowspan="1">0.009</td></tr><tr><td align="left" colspan="8" rowspan="1">Metropolitan status, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Metropolitan</td><td char="(" align="char" colspan="1" rowspan="1">31,594 (76.6)</td><td char="(" align="char" colspan="1" rowspan="1">16,799 (74.7)</td><td char="(" align="char" colspan="1" rowspan="1">13,069 (78.2)</td><td char="(" align="char" colspan="1" rowspan="1">1726 (83.4)</td><td char="." align="char" colspan="1" rowspan="1">0.131</td><td char="." align="char" colspan="1" rowspan="1">0.215</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.084</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Non-metropolitan</td><td char="(" align="char" colspan="1" rowspan="1">5192 (12.6)</td><td char="(" align="char" colspan="1" rowspan="1">3183 (14.1)</td><td char="(" align="char" colspan="1" rowspan="1">1829 (10.9)</td><td char="(" align="char" colspan="1" rowspan="1">180 (8.7)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.076</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.172</td><td char="." align="char" colspan="1" rowspan="1">0.097</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Unknown</td><td char="(" align="char" colspan="1" rowspan="1">4485 (10.9)</td><td char="(" align="char" colspan="1" rowspan="1">2515 (11.2)</td><td char="(" align="char" colspan="1" rowspan="1">1806 (10.8)</td><td char="(" align="char" colspan="1" rowspan="1">164 (7.9)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.099</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.111</td><td char="." align="char" colspan="1" rowspan="1">0.012</td></tr><tr><td align="left" colspan="8" rowspan="1">Insurance plan, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;PPO</td><td char="(" align="char" colspan="1" rowspan="1">20,969 (50.8)</td><td char="(" align="char" colspan="1" rowspan="1">11,473 (51.0)</td><td char="(" align="char" colspan="1" rowspan="1">8526 (51.0)</td><td char="(" align="char" colspan="1" rowspan="1">970 (46.9)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.084</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.083</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Comprehensive</td><td char="(" align="char" colspan="1" rowspan="1">2841 (6.9)</td><td char="(" align="char" colspan="1" rowspan="1">1857 (8.3)</td><td char="(" align="char" colspan="1" rowspan="1">862 (5.2)</td><td char="(" align="char" colspan="1" rowspan="1">122 (5.9)</td><td char="." align="char" colspan="1" rowspan="1">0.032</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.092</td><td char="." align="char" colspan="1" rowspan="1">0.124</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;HMO</td><td char="(" align="char" colspan="1" rowspan="1">4879 (11.8)</td><td char="(" align="char" colspan="1" rowspan="1">2692 (12.0)</td><td char="(" align="char" colspan="1" rowspan="1">1955 (11.7)</td><td char="(" align="char" colspan="1" rowspan="1">232 (11.2)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.016</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.024</td><td char="." align="char" colspan="1" rowspan="1">0.008</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;POS</td><td char="(" align="char" colspan="1" rowspan="1">2680 (6.5)</td><td char="(" align="char" colspan="1" rowspan="1">1497 (6.7)</td><td char="(" align="char" colspan="1" rowspan="1">1020 (6.1)</td><td char="(" align="char" colspan="1" rowspan="1">163 (7.9)</td><td char="." align="char" colspan="1" rowspan="1">0.069</td><td char="." align="char" colspan="1" rowspan="1">0.047</td><td char="." align="char" colspan="1" rowspan="1">0.022</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Others<sup>a</sup></td><td char="(" align="char" colspan="1" rowspan="1">9277 (22.5)</td><td char="(" align="char" colspan="1" rowspan="1">4627 (20.6)</td><td char="(" align="char" colspan="1" rowspan="1">4098 (24.5)</td><td char="(" align="char" colspan="1" rowspan="1">552 (26.7)</td><td char="." align="char" colspan="1" rowspan="1">0.049</td><td char="." align="char" colspan="1" rowspan="1">0.144</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.095</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Unknown</td><td char="(" align="char" colspan="1" rowspan="1">625 (1.5)</td><td char="(" align="char" colspan="1" rowspan="1">351 (1.6)</td><td char="(" align="char" colspan="1" rowspan="1">243 (1.5)</td><td char="(" align="char" colspan="1" rowspan="1">31 (1.5)</td><td char="." align="char" colspan="1" rowspan="1">0.004</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.005</td><td char="." align="char" colspan="1" rowspan="1">0.009</td></tr><tr><td align="left" colspan="8" rowspan="1">Charlson comorbidity, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;0</td><td char="(" align="char" colspan="1" rowspan="1">32,619 (79.0)</td><td char="(" align="char" colspan="1" rowspan="1">17,419 (77.4)</td><td char="(" align="char" colspan="1" rowspan="1">13,535 (81.0)</td><td char="(" align="char" colspan="1" rowspan="1">1665 (80.4)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.015</td><td char="." align="char" colspan="1" rowspan="1">0.074</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.089</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1</td><td char="(" align="char" colspan="1" rowspan="1">5822 (14.1)</td><td char="(" align="char" colspan="1" rowspan="1">3257 (14.5)</td><td char="(" align="char" colspan="1" rowspan="1">2268 (13.6)</td><td char="(" align="char" colspan="1" rowspan="1">297 (14.3)</td><td char="." align="char" colspan="1" rowspan="1">0.022</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.004</td><td char="." align="char" colspan="1" rowspan="1">0.026</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2+&#8201;</td><td char="(" align="char" colspan="1" rowspan="1">2830 (6.9)</td><td char="(" align="char" colspan="1" rowspan="1">1821 (8.1)</td><td char="(" align="char" colspan="1" rowspan="1">901 (5.4)</td><td char="(" align="char" colspan="1" rowspan="1">108 (5.2)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.008</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.116</td><td char="." align="char" colspan="1" rowspan="1">0.108</td></tr><tr><td align="left" colspan="1" rowspan="1">Tobacco abuse/history, <italic toggle="yes">n</italic> (%)</td><td char="(" align="char" colspan="1" rowspan="1">3038 (7.4)</td><td char="(" align="char" colspan="1" rowspan="1">1705 (7.6)</td><td char="(" align="char" colspan="1" rowspan="1">1181 (7.1)</td><td char="(" align="char" colspan="1" rowspan="1">152 (7.3)</td><td char="." align="char" colspan="1" rowspan="1">0.011</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.009</td><td char="." align="char" colspan="1" rowspan="1">0.020</td></tr><tr><td align="left" colspan="1" rowspan="1">Obesity/overweight, <italic toggle="yes">n</italic> (%)</td><td char="(" align="char" colspan="1" rowspan="1">3738 (9.1)</td><td char="(" align="char" colspan="1" rowspan="1">1939 (8.6)</td><td char="(" align="char" colspan="1" rowspan="1">1538 (9.2)</td><td char="(" align="char" colspan="1" rowspan="1">261 (12.6)</td><td char="." align="char" colspan="1" rowspan="1">0.109</td><td char="." align="char" colspan="1" rowspan="1">0.130</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.021</td></tr><tr><td align="left" colspan="1" rowspan="1">Alcohol abuse/history, <italic toggle="yes">n</italic> (%)</td><td char="(" align="char" colspan="1" rowspan="1">325 (0.8)</td><td char="(" align="char" colspan="1" rowspan="1">196 (0.9)</td><td char="(" align="char" colspan="1" rowspan="1">118 (0.7)</td><td char="(" align="char" colspan="1" rowspan="1">11 (0.5)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.022</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.041</td><td char="." align="char" colspan="1" rowspan="1">0.019</td></tr><tr><td align="left" colspan="1" rowspan="1">Mental health problem (%)</td><td char="(" align="char" colspan="1" rowspan="1">3354 (8.1)</td><td char="(" align="char" colspan="1" rowspan="1">1782 (7.9)</td><td char="(" align="char" colspan="1" rowspan="1">1396 (8.4)</td><td char="(" align="char" colspan="1" rowspan="1">176 (8.5)</td><td char="." align="char" colspan="1" rowspan="1">0.005</td><td char="." align="char" colspan="1" rowspan="1">0.021</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.016</td></tr><tr><td align="left" colspan="8" rowspan="1">Year of surgery, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2016</td><td char="(" align="char" colspan="1" rowspan="1">12,561 (30.4)</td><td char="(" align="char" colspan="1" rowspan="1">7678 (34.1)</td><td char="(" align="char" colspan="1" rowspan="1">4573 (27.4)</td><td char="(" align="char" colspan="1" rowspan="1">310 (15.0)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.307</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.457</td><td char="." align="char" colspan="1" rowspan="1">0.147</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2017</td><td char="(" align="char" colspan="1" rowspan="1">10,364 (25.1)</td><td char="(" align="char" colspan="1" rowspan="1">5970 (26.5)</td><td char="(" align="char" colspan="1" rowspan="1">3999 (23.9)</td><td char="(" align="char" colspan="1" rowspan="1">395 (19.1)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.118</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.178</td><td char="." align="char" colspan="1" rowspan="1">0.060</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2018</td><td char="(" align="char" colspan="1" rowspan="1">8527 (20.7)</td><td char="(" align="char" colspan="1" rowspan="1">4450 (19.8)</td><td char="(" align="char" colspan="1" rowspan="1">3610 (21.6)</td><td char="(" align="char" colspan="1" rowspan="1">467 (22.6)</td><td char="." align="char" colspan="1" rowspan="1">0.023</td><td char="." align="char" colspan="1" rowspan="1">0.068</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.045</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2019</td><td char="(" align="char" colspan="1" rowspan="1">7321 (17.7)</td><td char="(" align="char" colspan="1" rowspan="1">3359 (14.9)</td><td char="(" align="char" colspan="1" rowspan="1">3289 (19.7)</td><td char="(" align="char" colspan="1" rowspan="1">673 (32.5)</td><td char="." align="char" colspan="1" rowspan="1">0.295</td><td char="." align="char" colspan="1" rowspan="1">0.422</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.126</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2020</td><td char="(" align="char" colspan="1" rowspan="1">2498 (6.1)</td><td char="(" align="char" colspan="1" rowspan="1">1040 (4.6)</td><td char="(" align="char" colspan="1" rowspan="1">1233 (7.4)</td><td char="(" align="char" colspan="1" rowspan="1">225 (10.9)</td><td char="." align="char" colspan="1" rowspan="1">0.121</td><td char="." align="char" colspan="1" rowspan="1">0.235</td><td char="." align="char" colspan="1" rowspan="1">&#8722;&#8201;0.116</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">RAS</italic> robotic-assisted surgery, <italic toggle="yes">Lap</italic> laparoscopic surgery, <italic toggle="yes">Std Diff</italic> standardized difference, <italic toggle="yes">PPO</italic> Preferred Payer Organization, <italic toggle="yes">HMO</italic> Health Maintenance Organization, <italic toggle="yes">POS</italic> point-of-service</p><p><sup>a</sup>Others include basic/major medical benefits, exclusive provider organization, consumer driven health plan, and high deductible health plan</p></table-wrap-foot></table-wrap></p><p id="Par15">In IPTW adjusted analysis (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>), RAS was associated with 22% less likelihood of any opioid fill (OR 0.78, 95% CI 0.60 to 0.98, <italic toggle="yes">p</italic>&#8201;=&#8201;0.041), and 26% less likelihood of schedule II/III opioid fill (OR 0.74, 95% CI 0.56 to 0.96, <italic toggle="yes">p</italic>&#8201;=&#8201;0.029) in the long-term as compared to Lap. RAS and Lap were comparable in high-dose (&gt;&#8201;50 MME per day) opioid fill (<italic toggle="yes">p</italic>&#8201;=&#8201;0.840). As compared to Open, RAS was associated with 33% less likelihood of any opioid fill (OR 0.67, 95% CI 0.52 to 0.85, <italic toggle="yes">p</italic>&#8201;=&#8201;0.002), and 32% less likelihood of schedule II/III opioid fill (OR 0.68, 95% CI 0.51 to 0.88, <italic toggle="yes">p</italic>&#8201;=&#8201;0.004) in the long-term. RAS and Open were comparable in high-dose (&gt;&#8201;50 MME per day) opioid fill (<italic toggle="yes">p</italic>&#8201;=&#8201;0.860). There was no significantly different long-term opioid use between Lap versus Open in any opioid, schedule II/III opioid, and high-dose opioid fills (all <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05).<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Inverse probability of treatment weighting adjusted comparison of long-term opioid use between surgical approaches</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Opioid, <italic toggle="yes">n</italic> (%)</th><th align="left" colspan="4" rowspan="1">RAS versus lap</th><th align="left" colspan="4" rowspan="1">RAS versus open</th><th align="left" colspan="4" rowspan="1">Lap vs Open</th></tr><tr><th align="left" colspan="1" rowspan="1">Lap,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;16,700</th><th align="left" colspan="1" rowspan="1">RAS,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;2082</th><th align="left" colspan="1" rowspan="1">O.R. (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic></th><th align="left" colspan="1" rowspan="1">Open,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;22,495</th><th align="left" colspan="1" rowspan="1">RAS,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;2066</th><th align="left" colspan="1" rowspan="1">O.R. (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic></th><th align="left" colspan="1" rowspan="1">Open,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;22,493</th><th align="left" colspan="1" rowspan="1">Lap,<break/><italic toggle="yes">N</italic>&#8201;=&#8201;16,712</th><th align="left" colspan="1" rowspan="1">O.R. (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Any</td><td char="(" align="char" colspan="1" rowspan="1">762 (4.6)</td><td char="(" align="char" colspan="1" rowspan="1">75 (3.6)</td><td char="(" align="char" colspan="1" rowspan="1">0.78 (0.60&#8211;0.98)</td><td char="." align="char" colspan="1" rowspan="1">0.041</td><td char="(" align="char" colspan="1" rowspan="1">1124 (5.0)</td><td char="(" align="char" colspan="1" rowspan="1">71 (3.4)</td><td char="(" align="char" colspan="1" rowspan="1">0.67 (0.52&#8211;0.85)</td><td char="." align="char" colspan="1" rowspan="1">0.002</td><td char="(" align="char" colspan="1" rowspan="1">1109 (4.9)</td><td char="(" align="char" colspan="1" rowspan="1">781 (4.7)</td><td char="(" align="char" colspan="1" rowspan="1">0.95 (0.86&#8211;1.04)</td><td char="." align="char" colspan="1" rowspan="1">0.250</td></tr><tr><td align="left" colspan="1" rowspan="1">Schedule II/III</td><td char="(" align="char" colspan="1" rowspan="1">649 (3.9)</td><td char="(" align="char" colspan="1" rowspan="1">61 (2.9)</td><td char="(" align="char" colspan="1" rowspan="1">0.74 (0.56&#8211;0.96)</td><td char="." align="char" colspan="1" rowspan="1">0.029</td><td char="(" align="char" colspan="1" rowspan="1">944 (4.2)</td><td char="(" align="char" colspan="1" rowspan="1">60 (2.9)</td><td char="(" align="char" colspan="1" rowspan="1">0.68 (0.51&#8211;0.88)</td><td char="." align="char" colspan="1" rowspan="1">0.004</td><td char="(" align="char" colspan="1" rowspan="1">933 (4.1)</td><td char="(" align="char" colspan="1" rowspan="1">659 (3.9)</td><td char="(" align="char" colspan="1" rowspan="1">0.95 (0.86&#8211;1.05)</td><td char="." align="char" colspan="1" rowspan="1">0.310</td></tr><tr><td align="left" colspan="1" rowspan="1">High-dose<sup>a</sup></td><td char="(" align="char" colspan="1" rowspan="1">134 (0.8)</td><td char="(" align="char" colspan="1" rowspan="1">16 (0.8)</td><td char="(" align="char" colspan="1" rowspan="1">0.95 (0.54&#8211;1.55)</td><td char="." align="char" colspan="1" rowspan="1">0.840</td><td char="(" align="char" colspan="1" rowspan="1">198 (0.9)</td><td char="(" align="char" colspan="1" rowspan="1">17 (0.8)</td><td char="(" align="char" colspan="1" rowspan="1">0.96 (0.56&#8211;1.52)</td><td char="." align="char" colspan="1" rowspan="1">0.860</td><td char="(" align="char" colspan="1" rowspan="1">196 (0.9)</td><td char="(" align="char" colspan="1" rowspan="1">139 (0.8)</td><td char="(" align="char" colspan="1" rowspan="1">0.96 (0.77&#8211;1.19)</td><td char="." align="char" colspan="1" rowspan="1">0.710</td></tr></tbody></table><table-wrap-foot><p>All regression analyses were weighted by inverse probability of treatment weights (IPTW) estimated using logistic regression including baseline characteristics</p><p><italic toggle="yes">RAS</italic> robotic-assisted surgery, <italic toggle="yes">Lap</italic> laparoscopic surgery, <italic toggle="yes">MME</italic> morphine milligram equivalent, <italic toggle="yes">OR</italic> odds ratio, <italic toggle="yes">CI</italic> confidence interval</p><p><sup>a</sup>High-dose: Over 50 morphine milligram equivalent per day opioid fill</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec8"><title>Discussion</title><p id="Par16">In this retrospective review of opioid-na&#239;ve adults undergoing outpatient primary unilateral inguinal hernia in the Merative&#8482; MarketScan&#174; database, long-term use of any opioid and schedule II/III opioid was significantly decreased in a robotic-assisted surgery approach as compared to both laparoscopic and open approaches, while there was no significant difference in these outcomes between the laparoscopic and open approaches. High-dose long-term opioid use was present in less than 1% of patients and did not vary between surgical approaches. In our results, the statistical significance and the effect magnitude for RAS is likely underestimated as it is known that administrative claims databases fail to capture all RAS operations, incorrectly categorizing many of them as Lap [<xref ref-type="bibr" rid="CR21">21</xref>&#8211;<xref ref-type="bibr" rid="CR23">23</xref>]. The overall effect sizes for any long-term opioid use in the RAS group were moderate with an odds ratio of 0.78 compared to lap and 0.67 compared to open. This effect can have a great impact when considering the scale at which this operation is performed. When the overall rate of progressing to long-term opioid use identified in our sample (4.8%) is extrapolated to the 800,000 inguinal hernia repairs performed annually in the United States [<xref ref-type="bibr" rid="CR4">4</xref>], greater than 38,000 patients are progressing to long-term opioid use after inguinal hernia repair annually. In a population this large, a risk reduction of the magnitude identified in this study represents many thousands of patients.</p><p id="Par17">Our findings are consistent with findings of recent similar studies. The percentage of patients proceeding to long-term opioid use is comparable to that described by in the literature for general surgery operations (6&#8211;10%) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. A recent study by Howard et al. reported only 1.5% of patients developed new persistent opioid use after inguinal hernia repair, but the authors acknowledged that this may be an underestimate of the true rate [<xref ref-type="bibr" rid="CR24">24</xref>]. The long-term opioid use results from this analysis expand on the existing body of evidence regarding opioid use after inguinal hernia repair. Multiple studies have concluded that although MIS inguinal hernia repair has a shorter recovery time and less acute pain [<xref ref-type="bibr" rid="CR8">8</xref>], short-term opioid use does not differ by surgical approach [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. These studies generally have been limited by relatively small sample sizes. A study by Reinhorn et al. reported a significant difference in short-term opioid use after inguinal hernia repair by surgical approach, with less opioid use among the open surgery patients as compared to the MIS group [<xref ref-type="bibr" rid="CR9">9</xref>]. This study compared MIS posterior (preperitoneal) mesh placement to open posterior mesh placement, the latter of which is an uncommonly performed technique. The body of evidence on long-term opioid use after inguinal hernia repair is more limited. Howard et al. found that new persistent opioid use after inguinal hernia repair was decreased in laparoscopic surgery as compared to open, with an odds ratio of 0.89 [<xref ref-type="bibr" rid="CR24">24</xref>]. Robotic surgery was not assessed in that study.</p><p id="Par18">The mechanism by which RAS may reduce long-term opioid use compared to lap and open surgery has several potential explanations. The first and most intuitive possibility is that RAS produces less long-term pain. This explanation is especially plausible comparing RAS to open surgery. Though the quality of evidence is low, prior studies suggest that rates of developing chronic pain after inguinal hernia repair are greater for open repair than for MIS repair [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. No such difference in chronic pain rates has been demonstrated between RAS and lap approaches. Many benefits for RAS over lap surgery for inguinal hernia repair have been anecdotally described but are lacking in higher level evidence. These include improved three-dimensional visualization, minimization of tissue trauma, and improved visualization and protection of retroperitoneal neurovascular structures. The effect associated with RAS may also be due to differences in operative technique between RAS and lap approaches. For example, it may be more common to close the peritoneal flap with suture during RAS, while penetrating tacks may be more commonly used for this purpose in lap surgery. Tacks and other penetrating fixation methods increase the risk of injury to the ilioinguinal or iliohypogastic nerves as they traverse between muscle layers of the lateral abdominal wall, and the use of permanent tacks has been identified as a risk factor for requesting opioid prescription refill following inguinal hernia repair [<xref ref-type="bibr" rid="CR5">5</xref>]. The heterogeneity in surgical technique, even within a given surgical approach, leaves correlating technical aspects of surgery to outcomes in the realm of speculation.</p><p id="Par19">Further, there is no certainty that the difference in long-term opioid use is directly due to surgical approach or resultant amount of pain. Multiple studies have demonstrated that opioid use is associated with prescriber practice, with use increasing with larger number of MME prescribed following the operation [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Prescription size following surgery has also been associated with increased prescription refill requests and new persistent opioid use after inguinal hernia repair [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. It is possible that surgeons who are early-adopters of RAS may also be early-adopters of certain opioid prescribing or post-operative care practices that minimize long-term opioid use. Other potential confounding variables include the specifics of patient and approach selection by individual surgeons, which could not be measured in this sample.</p><p id="Par20">This study is limited by its reliance on claims data and the known limits in accuracy of these data, including the under capturing of RAS as described above. It is similarly unknown the reasons of opioid fill and how many patients who had a long-term opioid prescription fill progressed to become regular opioid users or fell victim to long-term opioid abuse or addiction. As such, generalizations about the contribution of these patterns to the overall opioid epidemic must be made with caution.</p></sec><sec id="Sec9"><title>Conclusion</title><p id="Par21">Overall, this analysis provides an important insight into the overall risk of progressing to long-term opioid use following inguinal hernia repair, and suggests that patients undergoing RAS has a decreased risk of long-term opioid use compared to those undergoing lap and open. This information may aid surgeons in selecting the optimal surgical approach for inguinal hernia repair, considering not only anesthetic and operative risk, but also risk of long-term opioid use. It remains in patients&#8217; best interests for surgeons to be competent in a range of options for inguinal hernia repair in order to provide optimal personalized recommendations.</p></sec><sec sec-type="supplementary-material"><sec id="Sec10"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="464_2024_11040_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary file1 (DOCX 22 kb)</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="funding-information"><title>Funding</title><p>Intuitive Surgical funded access to the Merative&#8482; MarketScan&#174; Research Databases.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Disclosures</title><p id="Par22">Gediwon Milky, I-Fan Shih, and Feibi Zheng report full-time employment and stock ownership at Intuitive Surgical. Ian T. MacQueen and David C. Chen have no conflicts of interest or financial ties to disclose.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Azadfard M, Huecker MR, Leaming JM (2023) Opioid addiction. StatPearls. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK448203/">https://www.ncbi.nlm.nih.gov/books/NBK448203/</ext-link>. Accessed 4 Dec 2023<pub-id pub-id-type="pmid">28846246</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lancet</surname><given-names>T</given-names></name></person-group><article-title>A time of crisis for the opioid epidemic in the USA</article-title><source>The Lancet</source><year>2021</year><volume>398</volume><issue>10297</issue><fpage>277</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)01653-6</pub-id><pub-id pub-id-type="pmcid">PMC8482059</pub-id><pub-id pub-id-type="pmid">34303422</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Lancet T (2021) A time of crisis for the opioid epidemic in the USA. The Lancet 398(10297):277. 10.1016/S0140-6736(21)01653-6<pub-id pub-id-type="doi">10.1016/S0140-6736(21)01653-6</pub-id><pub-id pub-id-type="pmcid">PMC8482059</pub-id><pub-id pub-id-type="pmid">34303422</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>JF</given-names></name><name name-style="western"><surname>Goesling</surname><given-names>J</given-names></name><etal/></person-group><article-title>New persistent opioid use after minor and major surgical procedures in US adults</article-title><source>JAMA Surg</source><year>2017</year><volume>152</volume><issue>6</issue><fpage>e170504</fpage><pub-id pub-id-type="doi">10.1001/JAMASURG.2017.0504</pub-id><pub-id pub-id-type="pmid">28403427</pub-id><pub-id pub-id-type="pmcid">PMC7050825</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Brummett CM, Waljee JF, Goesling J et al (2017) New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg 152(6):e170504. 10.1001/JAMASURG.2017.0504<pub-id pub-id-type="pmid">28403427</pub-id><pub-id pub-id-type="doi">10.1001/JAMASURG.2017.0504</pub-id><pub-id pub-id-type="pmcid">PMC7050825</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Morrison Z, Kashyap S, Nirujogi VL (2023) Adult inguinal hernia. StatPearls. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK537241/">https://www.ncbi.nlm.nih.gov/books/NBK537241/</ext-link>. Accessed 4 Dec 2023<pub-id pub-id-type="pmid">30725926</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gentle</surname><given-names>CK</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>JD</given-names></name><name name-style="western"><surname>Montelione</surname><given-names>KC</given-names></name><etal/></person-group><article-title>Opioid prescribing practices and patient-requested refill patterns following laparoscopic inguinal hernia repair</article-title><source>Hernia</source><year>2023</year><volume>27</volume><issue>1</issue><fpage>85</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1007/S10029-022-02708-5</pub-id><pub-id pub-id-type="pmid">36418792</pub-id><pub-id pub-id-type="pmcid">PMC9685134</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Gentle CK, Thomas JD, Montelione KC et al (2023) Opioid prescribing practices and patient-requested refill patterns following laparoscopic inguinal hernia repair. Hernia 27(1):85&#8211;92. 10.1007/S10029-022-02708-5<pub-id pub-id-type="pmid">36418792</pub-id><pub-id pub-id-type="doi">10.1007/S10029-022-02708-5</pub-id><pub-id pub-id-type="pmcid">PMC9685134</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knight</surname><given-names>AW</given-names></name><name name-style="western"><surname>Habermann</surname><given-names>EB</given-names></name><name name-style="western"><surname>Ubl</surname><given-names>DS</given-names></name><name name-style="western"><surname>Zielinski</surname><given-names>MD</given-names></name><name name-style="western"><surname>Thiels</surname><given-names>CA</given-names></name></person-group><article-title>Opioid utilization in minimally invasive versus open inguinal hernia repair</article-title><source>Surgery</source><year>2019</year><volume>166</volume><issue>5</issue><fpage>752</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.1016/J.SURG.2019.05.012</pub-id><pub-id pub-id-type="pmid">31229314</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Knight AW, Habermann EB, Ubl DS, Zielinski MD, Thiels CA (2019) Opioid utilization in minimally invasive versus open inguinal hernia repair. Surgery 166(5):752&#8211;757. 10.1016/J.SURG.2019.05.012<pub-id pub-id-type="pmid">31229314</pub-id><pub-id pub-id-type="doi">10.1016/J.SURG.2019.05.012</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miserez</surname><given-names>M</given-names></name><name name-style="western"><surname>Peeters</surname><given-names>E</given-names></name><name name-style="western"><surname>Aufenacker</surname><given-names>T</given-names></name><etal/></person-group><article-title>Update with level 1 studies of the European Hernia Society guidelines on the treatment of inguinal hernia in adult patients</article-title><source>Hernia</source><year>2014</year><volume>18</volume><issue>2</issue><fpage>151</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1007/S10029-014-1236-6</pub-id><pub-id pub-id-type="pmid">24647885</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Miserez M, Peeters E, Aufenacker T et al (2014) Update with level 1 studies of the European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia 18(2):151&#8211;163. 10.1007/S10029-014-1236-6<pub-id pub-id-type="pmid">24647885</pub-id><pub-id pub-id-type="doi">10.1007/S10029-014-1236-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simons</surname><given-names>MP</given-names></name><name name-style="western"><surname>Smietanski</surname><given-names>M</given-names></name><name name-style="western"><surname>Bonjer</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>International guidelines for groin hernia management</article-title><source>Hernia</source><year>2018</year><volume>22</volume><issue>1</issue><fpage>1</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1007/S10029-017-1668-X</pub-id><pub-id pub-id-type="pmcid">PMC5809582</pub-id><pub-id pub-id-type="pmid">29330835</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Simons MP, Smietanski M, Bonjer HJ et al (2018) International guidelines for groin hernia management. Hernia 22(1):1&#8211;165. 10.1007/S10029-017-1668-X<pub-id pub-id-type="doi">10.1007/S10029-017-1668-X</pub-id><pub-id pub-id-type="pmcid">PMC5809582</pub-id><pub-id pub-id-type="pmid">29330835</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinhorn</surname><given-names>M</given-names></name><name name-style="western"><surname>Fullington</surname><given-names>N</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>D</given-names></name><etal/></person-group><article-title>Posterior mesh inguinal hernia repairs: a propensity score matched analysis of laparoscopic and robotic versus open approaches</article-title><source>Hernia</source><year>2023</year><volume>27</volume><issue>1</issue><fpage>93</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1007/S10029-022-02680-0</pub-id><pub-id pub-id-type="pmid">36125632</pub-id><pub-id pub-id-type="pmcid">PMC9931785</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Reinhorn M, Fullington N, Agarwal D et al (2023) Posterior mesh inguinal hernia repairs: a propensity score matched analysis of laparoscopic and robotic versus open approaches. Hernia 27(1):93&#8211;104. 10.1007/S10029-022-02680-0<pub-id pub-id-type="pmid">36125632</pub-id><pub-id pub-id-type="doi">10.1007/S10029-022-02680-0</pub-id><pub-id pub-id-type="pmcid">PMC9931785</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheldon</surname><given-names>RR</given-names></name><name name-style="western"><surname>Do</surname><given-names>WS</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>JB</given-names></name><name name-style="western"><surname>Forte</surname><given-names>DM</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>VY</given-names></name></person-group><article-title>Sage wisdom or anecdotal dictum? Equivalent opioid use after open, laparoscopic, and robotic inguinal hernia repair</article-title><source>Am J Surg</source><year>2019</year><volume>217</volume><issue>5</issue><fpage>839</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/J.AMJSURG.2019.02.022</pub-id><pub-id pub-id-type="pmid">30827531</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Sheldon RR, Do WS, Weiss JB, Forte DM, Sohn VY (2019) Sage wisdom or anecdotal dictum? Equivalent opioid use after open, laparoscopic, and robotic inguinal hernia repair. Am J Surg 217(5):839&#8211;842. 10.1016/J.AMJSURG.2019.02.022<pub-id pub-id-type="pmid">30827531</pub-id><pub-id pub-id-type="doi">10.1016/J.AMJSURG.2019.02.022</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perez</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Petro</surname><given-names>CC</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Predictors of low and high opioid tablet consumption after inguinal hernia repair: an ACHQC opioid reduction task force analysis</article-title><source>Hernia</source><year>2022</year><volume>26</volume><issue>6</issue><fpage>1625</fpage><lpage>1633</lpage><pub-id pub-id-type="doi">10.1007/S10029-022-02661-3</pub-id><pub-id pub-id-type="pmid">36036822</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Perez AJ, Petro CC, Higgins RM et al (2022) Predictors of low and high opioid tablet consumption after inguinal hernia repair: an ACHQC opioid reduction task force analysis. Hernia 26(6):1625&#8211;1633. 10.1007/S10029-022-02661-3<pub-id pub-id-type="pmid">36036822</pub-id><pub-id pub-id-type="doi">10.1007/S10029-022-02661-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Merative (2021) Merative<sup>TM</sup> MarketScan&#174; Research Databases: Commercial Database &amp; Medicare Database user guide. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.merative.com/content/dam/merative/documents/brief/marketscan-explainer-general.pdf">https://www.merative.com/content/dam/merative/documents/brief/marketscan-explainer-general.pdf</ext-link>. Accessed 12 Aug 2023</mixed-citation></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bastawrous</surname><given-names>AL</given-names></name><name name-style="western"><surname>Brockhaus</surname><given-names>KK</given-names></name><name name-style="western"><surname>Chang</surname><given-names>MI</given-names></name><etal/></person-group><article-title>A national database propensity score-matched comparison of minimally invasive and open colectomy for long-term opioid use</article-title><source>Surg Endosc</source><year>2022</year><volume>36</volume><issue>1</issue><fpage>701</fpage><pub-id pub-id-type="doi">10.1007/S00464-021-08338-9</pub-id><pub-id pub-id-type="pmid">33569727</pub-id><pub-id pub-id-type="pmcid">PMC8741658</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Bastawrous AL, Brockhaus KK, Chang MI et al (2022) A national database propensity score-matched comparison of minimally invasive and open colectomy for long-term opioid use. Surg Endosc 36(1):701. 10.1007/S00464-021-08338-9<pub-id pub-id-type="pmid">33569727</pub-id><pub-id pub-id-type="doi">10.1007/S00464-021-08338-9</pub-id><pub-id pub-id-type="pmcid">PMC8741658</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santosa</surname><given-names>KB</given-names></name><name name-style="western"><surname>Hu</surname><given-names>HM</given-names></name><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name><etal/></person-group><article-title>New persistent opioid use among older patients following surgery: a Medicare claims analysis</article-title><source>Surgery</source><year>2020</year><volume>167</volume><issue>4</issue><fpage>732</fpage><pub-id pub-id-type="doi">10.1016/J.SURG.2019.04.016</pub-id><pub-id pub-id-type="pmid">31349994</pub-id><pub-id pub-id-type="pmcid">PMC7216555</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Santosa KB, Hu HM, Brummett CM et al (2020) New persistent opioid use among older patients following surgery: a Medicare claims analysis. Surgery 167(4):732. 10.1016/J.SURG.2019.04.016<pub-id pub-id-type="pmid">31349994</pub-id><pub-id pub-id-type="doi">10.1016/J.SURG.2019.04.016</pub-id><pub-id pub-id-type="pmcid">PMC7216555</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">United States Drug Enforcement Administration (2018) Drug scheduling. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.dea.gov/drug-information/drug-scheduling">https://www.dea.gov/drug-information/drug-scheduling</ext-link>. Accessed 9 Dec 2023</mixed-citation></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowell</surname><given-names>D</given-names></name><name name-style="western"><surname>Ragan</surname><given-names>KR</given-names></name><name name-style="western"><surname>Jones</surname><given-names>CM</given-names></name><name name-style="western"><surname>Baldwin</surname><given-names>GT</given-names></name><name name-style="western"><surname>Chou</surname><given-names>R</given-names></name></person-group><article-title>CDC clinical practice guideline for prescribing opioids for pain&#8212;United States, 2022</article-title><source>MMWR Recomm Rep</source><year>2023</year><volume>71</volume><issue>3</issue><fpage>1</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.15585/MMWR.RR7103A1</pub-id><pub-id pub-id-type="pmcid">PMC9639433</pub-id><pub-id pub-id-type="pmid">36327391</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R (2023) CDC clinical practice guideline for prescribing opioids for pain&#8212;United States, 2022. MMWR Recomm Rep 71(3):1&#8211;95. 10.15585/MMWR.RR7103A1<pub-id pub-id-type="doi">10.15585/MMWR.RR7103A1</pub-id><pub-id pub-id-type="pmcid">PMC9639433</pub-id><pub-id pub-id-type="pmid">36327391</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charlson</surname><given-names>M</given-names></name><name name-style="western"><surname>Szatrowski</surname><given-names>TP</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>J</given-names></name><name name-style="western"><surname>Gold</surname><given-names>J</given-names></name></person-group><article-title>Validation of a combined comorbidity index</article-title><source>J Clin Epidemiol</source><year>1994</year><volume>47</volume><issue>11</issue><fpage>1245</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1016/0895-4356(94)90129-5</pub-id><pub-id pub-id-type="pmid">7722560</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245&#8211;1251. 10.1016/0895-4356(94)90129-5<pub-id pub-id-type="pmid">7722560</pub-id><pub-id pub-id-type="doi">10.1016/0895-4356(94)90129-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quan</surname><given-names>H</given-names></name><name name-style="western"><surname>Sundararajan</surname><given-names>V</given-names></name><name name-style="western"><surname>Halfon</surname><given-names>P</given-names></name><etal/></person-group><article-title>Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data</article-title><source>Med Care</source><year>2005</year><volume>43</volume><issue>11</issue><fpage>1130</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1097/01.MLR.0000182534.19832.83</pub-id><pub-id pub-id-type="pmid">16224307</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130&#8211;1139. 10.1097/01.MLR.0000182534.19832.83<pub-id pub-id-type="pmid">16224307</pub-id><pub-id pub-id-type="doi">10.1097/01.MLR.0000182534.19832.83</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Austin</surname><given-names>PC</given-names></name><name name-style="western"><surname>Stuart</surname><given-names>EA</given-names></name></person-group><article-title>Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies</article-title><source>Stat Med</source><year>2015</year><volume>34</volume><issue>28</issue><fpage>3661</fpage><lpage>3679</lpage><pub-id pub-id-type="doi">10.1002/SIM.6607</pub-id><pub-id pub-id-type="pmid">26238958</pub-id><pub-id pub-id-type="pmcid">PMC4626409</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34(28):3661&#8211;3679. 10.1002/SIM.6607<pub-id pub-id-type="pmid">26238958</pub-id><pub-id pub-id-type="doi">10.1002/SIM.6607</pub-id><pub-id pub-id-type="pmcid">PMC4626409</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">R Core Team (2022) R: a language and environment for statistical computing. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>. Accessed 12 Jan 2023</mixed-citation></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shenoy</surname><given-names>R</given-names></name><name name-style="western"><surname>Mederos</surname><given-names>MA</given-names></name><name name-style="western"><surname>Jacob</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Robot-assisted general surgery procedures at the Veterans Health Administration: a comparison of surgical techniques</article-title><source>J Surg Res</source><year>2022</year><volume>279</volume><fpage>330</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/J.JSS.2022.06.032</pub-id><pub-id pub-id-type="pmid">35810550</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Shenoy R, Mederos MA, Jacob RL et al (2022) Robot-assisted general surgery procedures at the Veterans Health Administration: a comparison of surgical techniques. J Surg Res 279:330&#8211;337. 10.1016/J.JSS.2022.06.032<pub-id pub-id-type="pmid">35810550</pub-id><pub-id pub-id-type="doi">10.1016/J.JSS.2022.06.032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>JC</given-names></name><name name-style="western"><surname>Chughtai</surname><given-names>B</given-names></name><name name-style="western"><surname>O&#8217;Malley</surname><given-names>P</given-names></name><etal/></person-group><article-title>Perioperative outcomes, health care costs, and survival after robotic-assisted versus open radical cystectomy: a national comparative effectiveness study</article-title><source>Eur Urol</source><year>2016</year><volume>70</volume><issue>1</issue><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/J.EURURO.2016.03.028</pub-id><pub-id pub-id-type="pmid">27133087</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Hu JC, Chughtai B, O&#8217;Malley P et al (2016) Perioperative outcomes, health care costs, and survival after robotic-assisted versus open radical cystectomy: a national comparative effectiveness study. Eur Urol 70(1):195&#8211;202. 10.1016/J.EURURO.2016.03.028<pub-id pub-id-type="pmid">27133087</pub-id><pub-id pub-id-type="doi">10.1016/J.EURURO.2016.03.028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S-H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wren</surname><given-names>SM</given-names></name></person-group><article-title>A retrospective study of laparoscopic, robotic-assisted, and open emergent/urgent cholecystectomy based on the PINC AI Healthcare Database 2017&#8211;2020</article-title><source>World J Emerg Surg</source><year>2023</year><volume>18</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1186/S13017-023-00521-8</pub-id><pub-id pub-id-type="pmid">38037087</pub-id><pub-id pub-id-type="pmcid">PMC10687827</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Campbell S, Lee S-H, Liu Y, Wren SM (2023) A retrospective study of laparoscopic, robotic-assisted, and open emergent/urgent cholecystectomy based on the PINC AI Healthcare Database 2017&#8211;2020. World J Emerg Surg 18(1):1&#8211;12. 10.1186/S13017-023-00521-8<pub-id pub-id-type="pmid">38037087</pub-id><pub-id pub-id-type="doi">10.1186/S13017-023-00521-8</pub-id><pub-id pub-id-type="pmcid">PMC10687827</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>R</given-names></name><name name-style="western"><surname>Gunaseelan</surname><given-names>V</given-names></name><name name-style="western"><surname>Brummett</surname><given-names>C</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>J</given-names></name><name name-style="western"><surname>Englesbe</surname><given-names>M</given-names></name><name name-style="western"><surname>Telem</surname><given-names>D</given-names></name></person-group><article-title>New persistent opioid use after inguinal hernia repair</article-title><source>Ann Surg</source><year>2022</year><volume>276</volume><issue>5</issue><fpage>E577</fpage><lpage>E583</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000004560</pub-id><pub-id pub-id-type="pmid">33065653</pub-id><pub-id pub-id-type="pmcid">PMC8289484</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Howard R, Gunaseelan V, Brummett C, Waljee J, Englesbe M, Telem D (2022) New persistent opioid use after inguinal hernia repair. Ann Surg 276(5):E577&#8211;E583. 10.1097/SLA.0000000000004560<pub-id pub-id-type="pmid">33065653</pub-id><pub-id pub-id-type="doi">10.1097/SLA.0000000000004560</pub-id><pub-id pub-id-type="pmcid">PMC8289484</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>